文献速递系统性红斑狼疮

狼疮B细胞STAT1表达升高而非磷酸化与疾病活动度及浆母细胞易感性相关

Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

该研究通过流式细胞术分析21例健康对照、10例类风湿关节炎、7例原发性干燥综合征和22例SLE患者B细胞与T细胞中STAT1、pSTAT1、STAT3及pSTAT3的表达,发现SLE患者B细胞和T细胞亚群STAT1表达显著升高而非pSTAT1,且B细胞STAT1升高与SLEDAI及单核细胞Siglec-1(I型IFN标志物)显著相关;浆母细胞STAT1活化依赖IFNα,单核细胞则依赖IFNγ。

要点

  • SLE患者B细胞和T细胞亚群STAT1表达升高,但pSTAT1未见升高。
  • B细胞STAT1表达与SLEDAI及单核细胞Siglec-1显著相关。
  • 浆母细胞STAT1活化依赖IFNα,提示JAK抑制剂可能控制浆母细胞诱导。

核心结论

  • SLE患者B细胞STAT1表达升高而非磷酸化,与疾病活动度和I型IFN标志物相关,是连接I型IFN与B细胞异常两个致病特征的关键节点。

研究设计与样本

  • 研究纳入21例健康对照、10例类风湿关节炎、7例原发性干燥综合征和22例SLE患者,用流式细胞术分析B细胞和T细胞中STAT1、pSTAT1、STAT3及pSTAT3表达。
  • 进一步在SLE患者和健康对照的外周血单个核细胞中检测IFNα和IFNγ孵育后STAT1和STAT3表达及磷酸化。

主要发现

  • SLE患者B细胞和T细胞亚群中STAT1表达显著升高,但pSTAT1未见升高。
  • B细胞亚群STAT1表达升高与SLEDAI及单核细胞Siglec-1(I型IFN标志物)显著相关。
  • 浆母细胞中STAT1活化依赖IFNα,而单核细胞中STAT1活化依赖IFNγ。

临床怎么用

  • JAK抑制剂靶向JAK-STAT通路可能阻断STAT1表达并控制SLE浆母细胞诱导,为SLE治疗提供潜在策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: SLE is characterized by two pathogenic key signatures, type I IFN and B-cell abnormalities. How these signatures are interrelated is not known. Type I-II IFN trigger activation of Janus kinase (JAK) - signal transducer and activator of transcription (STAT). JAK-STAT inhibition is an attractive therapeutic possibility for SLE. We assess STAT1 and STAT3 expression and phosphorylation at baseline and after IFN type I and II stimulation in B-cell subpopulations of SLE patients compared with other autoimmune diseases and healthy controls (HD) and related it to disease activity. METHODS: Expression of STAT1, pSTAT1, STAT3 and pSTAT3 in B and T cells of 21 HD, 10 rheumatoid arthritis (RA), seven primary Sjögren's (pSS) and 22 SLE patients was analysed by flow cytometry. STAT1 and STAT3 expression and phosphorylation in PBMCs (peripheral blood mononuclear cells) of SLE patients and HD after IFNα and IFNγ incubation were further investigated. RESULTS: SLE patients showed substantially higher STAT1 but not pSTAT1 in B- and T-cell subsets. Increased STAT1 expression in B-cell subsets correlated significantly with SLEDAI and Siglec-1 on monocytes, a type I IFN marker. STAT1 activation in plasmablasts was IFNα dependent while monocytes exhibited dependence on IFNγ. CONCLUSION: Enhanced expression of STAT1 by B-cell candidates as a key node of two immunopathogenic signatures (type I IFN and B-cells) related to important immunopathogenic pathways and lupus activity. We show that STAT1 is activated upon IFNα exposure in SLE plasmablasts. Thus, Jak inhibitors, targeting JAK-STAT pathways, hold a promise to block STAT1 expression and control plasmablast induction in SLE.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Aue A, Szelinski F, Weißenberg SY, et al. Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility. Rheumatology (Oxford). 2020. PMID: 32357246. doi:10.1093/rheumatology/keaa187

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。